JP2003530821A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003530821A5 JP2003530821A5 JP2001511161A JP2001511161A JP2003530821A5 JP 2003530821 A5 JP2003530821 A5 JP 2003530821A5 JP 2001511161 A JP2001511161 A JP 2001511161A JP 2001511161 A JP2001511161 A JP 2001511161A JP 2003530821 A5 JP2003530821 A5 JP 2003530821A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- polypeptide
- nucleotide sequence
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002773 nucleotide Substances 0.000 description 19
- 125000003729 nucleotide group Chemical group 0.000 description 19
- 102000039446 nucleic acids Human genes 0.000 description 18
- 108020004707 nucleic acids Proteins 0.000 description 18
- 150000007523 nucleic acids Chemical class 0.000 description 18
- 229920001184 polypeptide Polymers 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 239000013604 expression vector Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 125000003275 alpha amino acid group Chemical group 0.000 description 11
- 108010047068 Melanin-concentrating hormone receptor Proteins 0.000 description 8
- 102000006953 melanin-concentrating hormone receptor activity proteins Human genes 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 102400001132 Melanin-concentrating hormone Human genes 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14370699P | 1999-07-14 | 1999-07-14 | |
| US60/143,706 | 1999-07-14 | ||
| PCT/US2000/018733 WO2001005947A1 (en) | 1999-07-14 | 2000-07-10 | Melanin-concentrating hormone receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003530821A JP2003530821A (ja) | 2003-10-21 |
| JP2003530821A5 true JP2003530821A5 (enExample) | 2007-05-31 |
Family
ID=22505240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001511161A Withdrawn JP2003530821A (ja) | 1999-07-14 | 2000-07-10 | メラニン凝集ホルモン受容体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7198910B1 (enExample) |
| EP (1) | EP1200560A4 (enExample) |
| JP (1) | JP2003530821A (enExample) |
| CA (1) | CA2378917A1 (enExample) |
| WO (1) | WO2001005947A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221613B1 (en) | 1998-12-31 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| WO2002002744A2 (en) * | 2000-07-05 | 2002-01-10 | Synaptic Pharmaceutical Corporation | Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| EP1305341A1 (en) * | 2000-07-21 | 2003-05-02 | Merck & Co., Inc. | Dog melanin-concentrating hormone receptor |
| EP1373545A4 (en) * | 2001-03-22 | 2005-07-20 | Merck & Co Inc | Mch1r deficient mice |
| US7078187B2 (en) | 2001-04-19 | 2006-07-18 | Neurogen Corporation | Melanin concentrating hormone receptors |
| US7078484B2 (en) | 2001-04-19 | 2006-07-18 | Neurogen Corporation | Melanin concentrating hormone receptors |
| US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| EP1588139A4 (en) | 2001-05-31 | 2006-10-04 | Merck & Co Inc | Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| US7141391B2 (en) | 2001-11-13 | 2006-11-28 | Neurogen Corporation | Monkey and canine melanin concentrating hormone receptors |
| MXPA05004739A (es) | 2002-11-06 | 2005-08-02 | Tularik Inc | Compuestos heterociclicos fusionados. |
| EP1653960A4 (en) | 2003-08-13 | 2008-11-26 | Amgen Inc | MELANIN CONCENTRATION HORMONE RECEPTOR ANTAGONIST |
| WO2005040824A2 (en) * | 2003-10-24 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10511936A (ja) | 1994-12-16 | 1998-11-17 | スミスクライン・ビーチャム・コーポレイション | ヒトソマトスタチン様受容体 |
| EP0848060A3 (en) | 1996-12-11 | 2000-02-02 | Smithkline Beecham Corporation | Novel human 11CB splice variant |
| EP1042498A4 (en) | 1997-12-03 | 2003-05-07 | Smithkline Beecham Corp | METHOD FOR SEARCHING FOR AN AGONIST OR ANTAGONIST OF THE HUMAN 11 CB SPLICE VARIANT |
| WO2000015793A2 (en) * | 1998-09-17 | 2000-03-23 | Incyte Pharmaceuticals, Inc. | Human gpcr proteins |
| US6362326B1 (en) | 1998-12-22 | 2002-03-26 | Smithkline Beecham Corporation | 11 cby genomic sequence |
| DE69935159T2 (de) * | 1998-12-28 | 2007-10-25 | Takeda Pharmaceutical Co. Ltd. | Screening-verfahren |
| US6221613B1 (en) | 1998-12-31 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
-
2000
- 2000-07-10 CA CA002378917A patent/CA2378917A1/en not_active Abandoned
- 2000-07-10 JP JP2001511161A patent/JP2003530821A/ja not_active Withdrawn
- 2000-07-10 EP EP00947155A patent/EP1200560A4/en not_active Withdrawn
- 2000-07-10 US US10/031,014 patent/US7198910B1/en not_active Expired - Fee Related
- 2000-07-10 WO PCT/US2000/018733 patent/WO2001005947A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004267216A5 (enExample) | ||
| ES2537806T3 (es) | Método para la secreción y producción de alto nivel de proteína | |
| JP2003530821A5 (enExample) | ||
| JP2003501038A5 (enExample) | ||
| CA2257839A1 (en) | Gamma-heregulin | |
| JP2003532365A5 (enExample) | ||
| JP2002513556A5 (enExample) | ||
| JP2008545436A5 (enExample) | ||
| Eariy et al. | Identification of sequences regulating the transcription of a Dictyostclium gene selectively expressed in prespore cells | |
| CN106061511A (zh) | 用于增强的基因表达的构建体和序列 | |
| CA2186573A1 (en) | Sh2-containing inositol-phosphatase | |
| JPH11500907A (ja) | 膵島新生に関与するｉｎｇａｐタンパク質 | |
| JP2005507648A5 (enExample) | ||
| RU2001117860A (ru) | ГЕНЫ ГОМОЛОГИЧНЫХ ИММУНОДОМИНАНТНЫХ БЕЛКОВ МАССОЙ 28-КИЛОДАЛЬТОН Ehrlichia canis И ИХ ПРИМЕНЕНИЕ | |
| JP2003527073A5 (enExample) | ||
| Almenoff et al. | Induction of heat-stable enterotoxin receptor activity by a human Alu repeat | |
| JP2002523094A5 (enExample) | ||
| JP2003514549A5 (enExample) | ||
| JP2005509160A5 (enExample) | ||
| JP2002539762A5 (enExample) | ||
| JP2003507029A5 (enExample) | ||
| JP2003113111A5 (enExample) | ||
| JP2005507651A5 (enExample) | ||
| JP2004500055A5 (enExample) | ||
| JP2005034025A (ja) | 大腸菌での異種遺伝子発現を促進させるプラスミドベクター、組換え大腸菌、該組換え大腸菌を用いた化学物質製造法及び組換えタンパク質の製造法 |